AstraZeneca's AL amyloidosis drug fails to reduce mortality in phase 3 test - Fierce Biotech
AI and Machine Learning · CRO · Special Reports; Trending. Biologics · Clinical Development · Ophthalmology · Fierce 50 · Special Report · Awards Gala.
Read the original at Fierce Biotech ↗
- Topics
- Healthcare
- Tracked via
- “AI Falures”